Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Nanoparticle Contract Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
The Global Nanoparticle Contract Manufacturing Services Market was valued at USD 2.12 billion in 2023, and is expected to reach USD 3.2 billion by 2029, rising at a CAGR of 7.10%.
The Nanoparticle Contract Manufacturing Services Market is experiencing significant growth due to several key drivers. One of the primary factors is the increasing adoption of nanoparticles in the pharmaceutical and healthcare industries. Nanoparticles are revolutionizing drug delivery systems by enhancing bioavailability, targeting specific cells or tissues, and reducing side effects. The growing focus on precision medicine and personalized therapeutics has led to a surge in demand for nanoparticles in drug formulation and development, boosting the need for specialized contract manufacturing services.
The environmental and renewable energy sectors are also driving growth in this market. Nanoparticles are being increasingly used in applications such as water purification, pollution control, and solar energy systems. As global sustainability efforts intensify, the demand for innovative nanoparticle-based solutions is rising. This, combined with technological advancements in nanoparticle synthesis, such as green manufacturing processes and improved scalability, is fueling market expansion.
Regional Insights
In 2023, North America emerged as the dominant region in the Global Nanoparticle Contract Manufacturing Services Market, holding the largest market share. This is due to its advanced infrastructure, strong pharmaceutical and biotechnology sectors, and increasing focus on nanotechnology innovations. The region has established itself as a hub for nanoparticle development and contract manufacturing, driven by robust investments in research and development, favorable regulatory frameworks, and a high demand for cutting-edge medical and technological solutions.
The pharmaceutical and biotech industries in North America are major contributors to the market's growth. With the widespread adoption of nanoparticles in drug delivery systems, gene therapies, and vaccines, there is a significant demand for specialized contract manufacturing services. High-profile successes, such as mRNA-based vaccines relying on lipid nanoparticles, have amplified the region's focus on nanoparticle production. Leading pharmaceutical companies and research institutes in the United States and Canada continue to collaborate with contract manufacturers to scale up production while meeting stringent regulatory requirements.
The presence of well-established players in the nanoparticle manufacturing space, coupled with a strong network of academic and research institutions, enhances North America's competitive edge. These institutions drive innovation in nanoparticle synthesis, functionalization, and large-scale production methods. Government funding and initiatives aimed at advancing nanotechnology and its applications further propel the market's growth.
Key Market Players Profiled in the Nanoparticle Contract Manufacturing Services Market
- Fortis Life Sciences
- Baxter International, Inc.
- Merck KGaA
- Evonik Industries AG
- DPT Laboratories, Ltd.
- FUJIFILM Corporation
- Renejix Pharma Solutions
- Ascendia Pharmaceuticals
- Ardena Holding NV
- Encapsula NanoSciences LLC
Report Scope
In this report, the Global Nanoparticle Contract Manufacturing Services Market has been segmented into the following categories:
By Type
- Lipid
- Metal
- Others
By Application
- Therapeutics
- Diagnostics
- Others
By Manufacturing Scale
- Pre-clinical
- Clinical
- Commercial
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Key Attributes
| Report Attribute | Details |
| No. of Pages | 178 |
| Forecast Period | 2023-2029 |
| Estimated Market Value (USD) in 2023 | $2.12 Billion |
| Forecasted Market Value (USD) by 2029 | $3.2 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
Key Market Drivers
- Increasing Demand for Nanotechnology in Pharmaceuticals and Healthcare
- Advancements in Electronics and Semiconductors
- Technological Advancements in Nanoparticle Synthesis
Key Market Challenges
- High Costs of Production
- Complex Regulatory Frameworks
Key Market Trends
- Increasing Demand for Custom Nanoparticles
- Integration of Automation and Artificial Intelligence
For more information about this report visit https://www.researchandmarkets.com/r/sm3qfn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
